Finally, when SKOV-3 + MSC tumor-bearing mice were treated with reparixin, we observed a decrease in the levels of peritoneal CXCR1/2 ligands, suggesting that a CXCR1/2 blockade leads to a decrease in the expression of its ligands. Here, CXCR1 is linked to neoplasm.